CORE
🇺🇦Â
 make metadata, not war
Services
Research
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
2 research outputs found
Long Term Efficacy and Safety Results and Analysis of Dose Correlations from the Phase I/II Peginvera Study of Ropeginterferon Alfa-2b, a Novel IFNa-2b, in Polycythemia Vera Patient
Author
Alexander Egle
Bettina Gisslinger
+20Â more
Christoph Klade
Dominik Wolf
Ella Willenbacher
Ernst Schlögl
Gunther Gastl
Heinz Gisslinger
Josef Thaler
Maria Theresa Krauth
Martin Schalling
Michael Zörer
Nicole C.C. Them
Oleh Zagrijtschuk
Oliver Ammann-Mwathi
Pavla Kadlecova
Richard Greil
Robert Kralovics
Sarita Ban
Sonja Burgstaller
Thomas Melchardt
Veronika Buxhofer-Ausch
Publication venue
'American Society of Hematology'
Publication date
Field of study
No full text
Crossref
Four Weeks Administration Schedule of Ropeginterferon Alfa-2b (AOP2014/P1101) in Polycythemia Very Patients Allows Maintaining of Efficacy with Favorable Toxicity Profile in the Phase I/II Peginvera Stud
Author
Alexander Egle
Bettina Gisslinger
+20Â more
Christoph Klade
Dominik Wolf
Ella Willenbacher
Ernst Schlögl
Gunther Gastl
Heinz Gisslinger
Josef Thaler
Maria Theresa Krauth
Martin Schalling
Michael Zörer
Nicole C.C. Them
Oleh Zagrijtschuk
Oliver Ammann-Mwathi
Pavla Kadlecova
Richard Greil
Robert Kralovics
Sarita Ban
Sonja Burgstaller
Thomas Melchardt
Veronika Buxhofer-Ausch
Publication venue
'American Society of Hematology'
Publication date
Field of study
No full text
Crossref
No full text
